Alterations in pubertal timing following therapy for childhood malignancies

Endocrine Development

Volumn 15, Issue , 2009, Pages 25-39

  Armstrong, Gregory T ^a   Chow, Eric J ^b   Sklar, Charles A ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; GONADORELIN; GONADOTROPIN; GROWTH HORMONE; IFOSFAMIDE; LOMUSTINE; MELPHALAN; METHOTREXATE; PREDNISONE; PROCARBAZINE; THIOTEPA; VINBLASTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; BONE DENSITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; CLINICAL ASSESSMENT; DELAYED PUBERTY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; GONAD DYSFUNCTION; GROUPS BY AGE; GROWTH HORMONE DEFICIENCY; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFERTILITY; LEYDIG CELL; MALE; OVARY FOLLICLE; OVARY INSUFFICIENCY; PATIENT IDENTIFICATION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; REVIEW; SEXUAL DEVELOPMENT; SHORT STATURE; SKULL IRRADIATION; SURVIVOR; TESTIS DISEASE; ADOLESCENT; CENTRAL NERVOUS SYSTEM; CHILD; GONADAL DISEASE; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; PUBERTY; RADIOTHERAPY; TIME;

ADOLESCENT; CENTRAL NERVOUS SYSTEM; CHILD; CRANIAL IRRADIATION; GONADAL DISORDERS; HUMANS; NEOPLASMS; PUBERTY; RADIOTHERAPY; TIME FACTORS;

EID: 66149104736     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000207616     Document Type: Review

References (81)

1. Styne D, Grumbach MM: Puberty: ontogeny, neuroendocrinology, physiology, and disorders; in Kronenberg H (ed): Williams Textbook of Endocrinology, ed 11. Philadelphia, Saunders Elsevier, 2008, pp 969-1166.
2. Hewitt M, Weiner SL, Simone JV (eds): Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, National Academic Press, 2003.
3. Ries L, Eisner M P, Kosary CL: SEER Cancer Statistics Review, 1975-2002. Bethesda, National Cancer Institute, 2005.
4. Chumlea WC, Schubert CM, Roche AF, Kulin HE, Lee PA, Himes JH, Sun SS: Age at menarche and racial comparisons in US girls. Pediatrics 2003; 111:110-113.
5. Herman-Giddens ME, Kaplowitz PB, Wasserman R: Navigating the recent articles on girls' puberty in Pediatrics: what do we know and where do we go from here? Pediatrics 2004;113:911-917.
6. Whincup PH, Gilg JA, Odoki K, Taylor SJ, Cook DG: Age of menarche in contemporary British teenagers: survey of girls born between 1982 and 1986. BMJ 2001;322:1095-1096.
7. Tanner JM, Davies PS: Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985;107:317-329.
8. Partsch CJ, Heger S, Sippell WG: Management and outcome of central precocious puberty. Clin Endocrinol (Oxf) 2002;56:129-148.
9. Bridges NA, Christopher JA, Hindmarsh PC, Brook CG: Sexual precocity: sex incidence and aetiology. Arch Dis Child 1994;70:116-118.
10. Trivin C, Couto-Silva AC, Sainte-Rose C, Chemaitilly W, Kalifa C, Doz F, Zerah M, Brauner R: Presentation and evolution of organic central precocious puberty according to the type of CNS lesion. Clin Endocrinol (Oxf) 2006;65:239-245.
11. de Vries L, Lazar L, Phillip M: Craniopharyngi-oma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab 2003;16: 703-710.
12. Garnett MR, Puget S, Grill J, Sainte-Rose C: Craniopharyngioma. Orphanet J Rare Dis 2007;2:18.
13. Sklar CA, Grumbach MM, Kaplan SL, Conte FA: Hormonal and metabolic abnormalities associated with central nervous system germinoma in children and adolescents and the effect of therapy: report of 10 patients. J Clin Endocrinol Metab 1981;52:9-16.
14. Ogilvy-Stuart AL, Clayton PE, Shalet SM: Cranial irradiation and early puberty. J Clin Endocrinol Metab 1994;78:1282-1286.
15. Oberfield SE, Soranno D, Nirenberg A, Heller G, Allen JC, David R, Levine LS, Sklar CA: Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr Adolesc Med 1996;150:589-592.
16. Lannering B, Jansson C, Rosberg S, Albertsson-Wikland K: Increased LH and FSH secretion after cranial irradiation in boys. Med Pediatr Oncol 1997;29:280-287.
17. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P: Hypothalamicpituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328:87-94.
18. Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, Loeffler JS, Leibsch NJ, Klibanski A, Munzenrider JE: Hypothalamic/ pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2001;49:1079-1092.
19. Margolin JF, Steuber CP, Poplack DG: Acute lymphoblastic leukemia; in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology. Philadelphia, Lippincott Williams & Wilkins, 2006, pp 538-590.
20. Quigley C, Cowell C, Jimenez M, Burger H, Kirk J, Bergin M, Stevens M, Simpson J, Silink M: Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblas-tic leukemia. N Engl J Med 1989;321:143-151.
21. Moell C, Marky I, Hovi L, Kristinsson J, Rix M, Moe PJ, Garwicz S: Cerebral irradiation causes blunted pubertal growth in girls treated for acute leukemia. Med Pediatr Oncol 1994;22: 375-379.
22. Didcock E, Davies HA, Didi M, Ogilvy Stuart AL, Wales JK, Shalet SM: Pubertal growth in young adult survivors of childhood leukemia. J Clin Oncol 1995;13:2503-2507.
23. Groot-Loonen JJ, van Setten P, Otten BJ, van 't Hof MA, Lippens RJ, Stoelinga GB: Shortened and diminished pubertal growth in boys and girls treated for acute lymphoblastic leukaemia. Acta Paediatr 1996;85:1091-1095.
24. Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL, Sklar CA: Timing of menarche among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2008; 50:854-858.
25. Maneschi F, Fugardi MG, Corsello G, LoCurto M: Pubertal maturation in girls treated for childhood acute leukaemia. Eur J Pediatr 1991;150: 630-633.
26. Mills JL, Fears TR, Robison LL, Nicholson HS, Sklar CA, Byrne J: Menarche in a cohort of 188 long-term survivors of acute lymphoblastic leukemia. J Pediatr 1997;131:598-602.
27. Uruena M, Stanhope R, Chessells JM, Leiper AD: Impaired pubertal growth in acute lymphoblastic leukaemia. Arch Dis Child 1991;66:1403-1407.
28. Leiper AD, Stanhope R, Kitching P, Chessells JM: Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child 1987;62:1107-1112.
29. Stubberfield TG, Byrne GC, Jones TW: Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation. J Pediatr Hematol Oncol 1995;17:167-171.
30. Birkebaek NH, Fisker S, Clausen N, Tuovinen V, Sindet-Pedersen S, Christiansen JS: Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 1998;30:351-356.
31. Melin AE, Adan L, Leverger G, Souberbielle JC, Schaison G, Brauner R: Growth hormone secretion, puberty and adult height after cranial irradiation with 18 Gy for leukaemia. Eur J Pediatr 1998;157:703-707.
32. Hata M, Ogino I, Aida N, Saito K, Omura M, Kigasawa H, Toyoda Y, Tachibana K, Matsubara S, Inoue T: Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors. Int J Cancer 2001;96(suppl): 117-124.
33. Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL, Sklar CA: Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Pediatr 2007;150:370- 375, 375.e371.
34. Hokken-Koelega AC, van Doorn J W, Hahlen K, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL: Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study. Pediatr Res 1993;33:577-582.
35. Kaplowitz P: Precocious puberty: update on secular trends, definitions, diagnosis, and treatment. Adv Pediatr 2004;51:37-62.
36. Darzy KH, Shalet SM: Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 2005;8:203-211.
37. Armstrong GT, Sklar CA, Hudson MM, Robison LL: Long-term health status among survivors of childhood cancer: does sex matter? J Clin Oncol 2007;25:4477-4489.
38. Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gatta-maneni HR, Brennan BM, Shalet SM: Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 2003;88:3682-3689.
39. Rivarola MA, Mendilaharzu H, Warman M, Bel-gorosky A, Iorcansky S, Castellano M, Caresana A, Chaler E, Maceiras M: Endocrine disorders in 66 suprasellar and pineal tumors of patients with pre-pubertal and pubertal ages. Horm Res 1992;37:1-6.
40. Sanford RA, Muhlbauer MS: Craniopharyngioma in children. Neurol Clin 1991;9:453-465.
41. Toogood AA: Endocrine consequences of brain irradiation. Growth Horm IGF Res 2004;14(suppl A):S118-S124.
42. Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML: Radiation-induced hypopituita-rism is dose-dependent. Clin Endocrinol (Oxf) 1989;31:363-373.
43. Rappaport R, Brauner R, Czernichow P, Thibaud E, Renier D, Zucker JM, Lemerle J: Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab 1982;54:1164-1168.
44. Sklar C: Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 1999;33:2-8.
45. Sarafoglou K, Boulad F, Gillio A, Sklar C: Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997;130:210-216.
46. Brauner R, Caltabiano P, Rappaport R, Leverger G, Schaison G: Leydig cell insufficiency after tes-ticular irradiation for acute lymphoblastic leukemia. Horm Res 1988;30:111-114.
47. Shalet SM, Tsatsoulis A, Whitehead E, Read G: Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol 1989;120:161-165.
48. Sklar CA, Robison LL, Nesbit ME, Sather HN, Meadows AT, Ortega JA, Kim TH, Hammond GD: Effects of radiation on testicular function in long-term survivors of childhood acute lympho-blastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol 1990;8:1981-1987.
49. Castillo LA, Craft AW, Kernahan J, Evans RG, Aynsley-Green A: Gonadal function after 12-Gy testicular irradiation in childhood acute lympho-blastic leukaemia. Med Pediatr Oncol 1990;18: 185-189.
50. Shalet SM, Beardwell CG, Jacobs HS, Pearson D: Testicular function following irradiation of the human prepubertal testis. Clin Endocrinol (Oxf) 1978;9:483-490.
51. Kinsella TJ, Trivette G, Rowland J, Sorace R, Miller R, Fraass B, Steinberg SM, Glatstein E, Sherins RJ: Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease. J Clin Oncol 1989;7:718- 724.
52. Couto-Silva AC, Trivin C, Thibaud E, Esperou H, Michon J, Brauner R: Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant 2001;28: 67-75.
53. Sklar CA, Kim TH, Ramsay NK: Testicular function following bone marrow transplantation performed during or after puberty. Cancer 1984;53: 1498-1501.
54. Bakker B, Massa GG, Oostdijk W, Van Weel-Sip-man MH, Vossen JM, Wit JM: Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr 2000;159:31-37.
55. Leiper AD, Grant DB, Chessells JM: Gonadal function after testicular radiation for acute lymphoblastic leukaemia. Arch Dis Child 1986;61:53- 56.
56. Stillman RJ, Schinfeld JS, Schiff I, Gelber RD, Greenberger J, Larson M, Jaffe N, Li FP: Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 1981;139:62-66.
57. Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Robison LL, Sklar CA: Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006;91:1723- 1728.
58. Wallace WH, Thomson AB, Saran F, Kelsey TW: Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005;62:738-744.
59. Hamre MR, Robison LL, Nesbit ME, Sather HN, Meadows AT, Ortega JA, D'Angio GJ, Hammond GD: Effects of radiation on ovarian function in long-term survivors of childhood acute lympho-blastic leukemia: a report from the Children's Cancer Study Group. J Clin Oncol 1987;5:1759-1765.
60. Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR: Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol (R Coll Radiol) 1989;1:75-79.
61. Ortin T T, Shostak CA, Donaldson SS: Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys 1990;19:873-880.
62. Thibaud E, Ramirez M, Brauner R, Flamant F, Zucker JM, Fekete C, Rappaport R: Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr 1992;121:880-884.
63. Sklar C: Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr Suppl 1995;411:57-62.
64. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, Storb R, Sullivan KM, With-erspoon R P, Thomas ED: Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988;6:813-818.
65. Blatt J, Poplack DG, Sherins RJ: Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med 1981;304: 1121-1124.
66. Sklar CA: Growth and pubertal development in survivors of childhood cancer. Pediatrician 1991; 18:53-60.
67. Shalet SM, Hann IM, Lendon M, Morris Jones PH, Beardwell CG: Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Arch Dis Child 1981, 56:275-278.
68. Mackie EJ, Radford M, Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 1996;27: 74-78.
69. Kulkarni SS, Sastry PS, Saikia TK, Parikh PM, Gopal R, Advani SH: Gonadal function following ABVD therapy for Hodgkin's disease. Am J Clin Oncol 1997;20:354-357.
70. Howell SJ, Radford JA, Ryder WD, Shalet SM: Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. J Clin Oncol 1999;17:1493-1498.
71. Papadakis V, Vlachopapadopoulou E, Van Syckle K, Ganshaw L, Kalmanti M, Tan C, Sklar C: Gonadal function in young patients successfully treated for Hodgkin disease. Med Pediatr Oncol 1999;32:366-372.
72. Greenfield DM, Walters SJ, Coleman RE, Hancock BW, Eastell R, Davies HA, Snowden JA, Derogatis L, Shalet SM, Ross RJ: Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J Clin Endocrinol Metab 2007;92: 3476-3482.
73. van den Berg H, Furstner F, van den Bos C, Behrendt H: Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. Pediatr Blood Cancer 2004;42:210-215.
74. Bramswig JH, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G: The effects of different cumulative doses of chemotherapy on testicu-lar function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer 1990;65:1298-1302.
75. Aubier F, Flamant F, Brauner R, Caillaud JM, Chaussain JM, Lemerle J: Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol 1989;7:304-309.
76. Brennemann W, Stoffel-Wagner B, Helmers A, Mezger J, Jager N, Klingmuller D: Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. J Urol 1997;158: 844-850.
77. Siris ES, Leventhal BG, Vaitukaitis JL: Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med 1976;294:1143-1146.
78. Clayton PE, Shalet SM, Price DA, Jones PH: Ovarian function following chemotherapy for childhood brain tumours. Med Pediatr Oncol 1989;17:92-96.
79. Thibaud E, Rodriguez-Macias K, Trivin C, Espe-rou H, Michon J, Brauner R: Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 1998;21:287-290.
80. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF: Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998;22: 989-994.
81. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87:3045-3052.